Company Statement: Wright Medical Group and BioMimetic Therapeutics enter into agreement to combine businesses
MLex Summary: Global orthopedic and medical device company Wright Medical Group has announced a deal to acquire Nasdaq-listed biotechnology and regenerative medicine firm BioMimetic Therapeutics. Wright will pay up to $380...To view the full article, register now.
Already a subscriber? Click here to view full article